Deborah Dunsire - 09 Sep 2021 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Director
Signature
/s/ Gerald E. Quirk, as attorney-in-fact
Issuer symbol
SYRS
Transactions as of
09 Sep 2021
Net transactions value
$0
Form type
3
Filing time
10 Sep 2021, 17:27:37 UTC
Previous filing
23 Jul 2021
Next filing
02 Jun 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24: Power of Attorney